A peptide discussed in mitochondrial-derived peptide research and studied for cytoprotective and metabolic signalling effects. The discovery paper and its correction must be read together.

Why is it unusual for mitochondria to encode a peptide?

Mitochondria have their own genome, but associating a sequence with it does not, by itself, establish where a peptide is made. This distinction matters when reading the Humanin discovery paper.

How does Humanin relate to MOTS-c?

Both are discussed within mitochondrial-derived peptide research, but their experimental evidence differs. Humanin findings do not validate MOTS-c claims, or vice versa.

How strong is the evidence?

The field is new and the literature largely preclinical. Humanin holds no regulatory approval. Its main contribution so far has been conceptual rather than applied.

What makes Humanin unusual?

Humanin has a sequence association with the mitochondrial 16S rRNA region. The original paper alone does not establish an exclusive mitochondrial production pathway.

Why did mitochondrial-derived peptides change the field?

Because mitochondria had been understood as an organelle that receives instructions from the nucleus. A peptide encoded in mitochondrial DNA that acts as a signal to the rest of the cell suggests the conversation runs both ways, not one.

Research Library›Metabolic Research›Humanin

Mitochondrial-Derived Peptide

Humanin: Discovery, Signalling and Evidence Limits

A peptide studied in cellular stress and mitochondrial signalling research. Its name and classification should not be mistaken for proof of how it is produced in the body.

6 min read·4 studies cited·Updated September 2026

Evidence level

Preclinical only — animal and cell studies

What this level means

Quick Reference

Type	24-amino-acid mitochondrial-derived peptide
Sequence association	Mitochondrial 16S rRNA region; production requires separate evidence
Discovered	2001
Studied for	Cytoprotection, metabolic signalling

What Is Humanin?

Humanin is commonly discussed as a 24-amino-acid mitochondrial-derived peptide. The term describes a research classification; it should not substitute for evidence about transcription, translation or the cellular site of production.

The 2001 correction says the original work did not prove that the cDNA represented a gene, establish its genomic origin, or establish peptide production in vivo. We have removed the earlier claim that this experiment conclusively demonstrated a peptide produced from mitochondrial rather than nuclear DNA. Later studies must be assessed separately.

What the Research Examines

Humanin was identified in 2001 in surviving brain tissue from an Alzheimer’s patient, and early work examined its apparent protective effect on neurons under stress. Subsequent research has looked at cytoprotection more broadly, at insulin sensitivity, and at circulating levels that decline with age.

The mitochondrial-derived peptide field is genuinely new, and the literature is largely preclinical. Humanin has no regulatory approval anywhere. Its main significance so far has been conceptual: establishing that mitochondria participate in signalling rather than only in energy production.

Sequence and Production

Almost everything your body builds is specified by DNA in the cell nucleus. That is the main library, and for most of the history of biology it was assumed to be the only one that mattered.

Mitochondria have their own separate DNA — a small, circular genome, left over from an ancient bacterium that took up residence inside our ancestors' cells and never left. It was long treated as a vestige: a handful of genes for running the power plant, and nothing more.

Sequence similarity is a clue, not a complete production pathway. A proposed sequence, an experimentally expressed peptide and a naturally produced molecule are different kinds of evidence.

An experiment can study the effect of a prepared peptide without establishing where or how an organism naturally makes it. Keep those questions separate when comparing papers.

That is why mitochondrial-derived peptides changed the framing of the field. Mitochondria were understood as an organelle that gets told what to do; this suggests they also do some of the telling. The direction of the conversation was assumed to run one way, and it appears to run both.

Frequently Asked Questions

Compiled by the Southern Pacific Labs research team. Last updated September 2026.

Browse the research range →

Published References

Hashimoto Y, Niikura T, Tajima H, et al. “A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta.” Proceedings of the National Academy of Sciences of the United States of America, 2001. PubMed
The 2001 correction fixes an accession identifier and limits what the discovery paper established about genomic origin and in-vivo peptide production. It is not a verdict on subsequent research. View notice
Lee C, Yen K, Cohen P. “Humanin: a harbinger of mitochondrial-derived peptides?” Trends in endocrinology and metabolism: TEM, 2013. PubMed
Lee C, Zeng J, Drew BG, et al. “The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.” Cell metabolism, 2015. PubMed
Yen K, Lee C, Mehta H, et al. “The emerging role of the mitochondrial-derived peptide humanin in stress resistance.” Journal of molecular endocrinology, 2013. PubMed